Scribe Therapeutics, Inc (SCTX) insider trading
Every open-market stock purchase and sale by Scribe Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Behzad Aghazadeh (10% owner) and 5 others bought $71.3M in the last 90 days, more than doubling their stake.
Last 12 months: insiders bought $71.3M (6 buys) and sold $0 (0 sales). Last close $19.30 on Oct 21, 2026.
Recent SCTX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jul 28, 2026 | Behzad Aghazadeh (10% owner) | Bought | $144K |
| Jul 27, 2026 | Orbimed Advisors LLC (Director) | Bought | $15M |
| Jul 27, 2026 | Carl L Gordon (Director) | Bought | $15M |
| Jul 27, 2026 | AH Bio Fund II L.P. (Insider) | Bought | $5M |
| Jul 27, 2026 | AH Bio Fund II L.P. (Insider) | Bought (not open market) | — |
| Jul 27, 2026 | AH Bio Fund II L.P. (Insider) | Bought (not open market) | — |
| Jul 27, 2026 | Carl L Gordon (Director) | Bought (not open market) | — |
| Jul 27, 2026 | Carl L Gordon (Director) | Bought (not open market) | — |
| Jul 27, 2026 | Orbimed Advisors LLC (Director) | Bought (not open market) | — |
| Jul 27, 2026 | Orbimed Advisors LLC (Director) | Bought (not open market) | — |
| Jul 27, 2026 | AH Bio Fund II L.P. (Insider) | Bought (not open market) | — |
| Jul 27, 2026 | Jennifer A Doudna (Insider) | Bought (not open market) | — |
| Jul 27, 2026 | Jennifer A Doudna (Insider) | Bought (not open market) | — |
| Jul 27, 2026 | AH Bio Fund II L.P. (Insider) | Bought (not open market) | — |
| Jul 24, 2026 | Behzad Aghazadeh (10% owner) | Bought | $35M |
| Jul 24, 2026 | Behzad Aghazadeh (10% owner) | Bought | $1.1M |
| Jul 23, 2026 | Svetlana Lucas (C-suite exec) | Bought | $45K |
| Jul 23, 2026 | David Parrot (CFO) | Bought | $20K |
| Jul 23, 2026 | Benjamin L. Oakes (CEO) | Bought (not open market) | — |
| Jul 23, 2026 | Benjamin L. Oakes (CEO) | Bought (not open market) | — |
| Jul 23, 2026 | Joshua Bleharski (Insider) | Bought (not open market) | — |
| Jul 23, 2026 | Svetlana Lucas (C-suite exec) | Bought (not open market) | — |
| Jul 23, 2026 | Carl L Gordon (Insider) | Bought (not open market) | — |
| Jul 23, 2026 | Brett Staahl (Insider) | Bought (not open market) | — |
| Jul 23, 2026 | Behzad Aghazadeh (Director) | Bought (not open market) | — |
Who's trading SCTX
- Behzad Aghazadeh, 10% owner: bought $36.3M (3 buys), last Jul 28, 2026
- Orbimed Advisors LLC, Director: bought $15M (1 buy), last Jul 27, 2026
- Jennifer A Doudna, Insider: other filings, last Jul 27, 2026
- Carl L Gordon, Director: bought $15M (1 buy), last Jul 27, 2026
- AH Bio Fund II L.P., Insider: bought $5M (1 buy), last Jul 27, 2026
- Brett Staahl, Insider: other filings, last Jul 23, 2026
- James Dean Watson, Insider: other filings, last Jul 23, 2026
- Joshua Bleharski, Insider: other filings, last Jul 23, 2026
- Svetlana Lucas, C-suite exec: bought $45K (1 buy), last Jul 23, 2026
- Benjamin L. Oakes, CEO: other filings, last Jul 23, 2026
- David Parrot, CFO: bought $20K (1 buy), last Jul 23, 2026
Get free alerts when an insider at Scribe Therapeutics, Inc files a new trade →